DEND syndrome due to V59A mutation in KCNJ11 gene: unresponsive to sulfonylureas

被引：11

作者：

Itoh, Sachie ^{[2
]}

Matsuoka, Hisafumi ^{[1
]}

Yasuda, Yuki ^{[2
]}

Miyake, Nobuka ^{[2
]}

Suzuki, Keiko ^{[2
]}

Yorifuji, Tohru ^{[3
]}

Sugihara, Shigetaka ^{[2
]}

机构：

[1] Tokyo Womens Med Univ Med Ctr East, Dept Pediat, Arakawa Ku, Tokyo 1168567, Japan

[2] Tokyo Womens Med Univ Med Ctr East, Dept Pediat, Tokyo 1168567, Japan

[3] Osaka City Gen Hosp, Dept Pediat Endocrinol & Metab, Childrens Med Ctr, Osaka, Japan

来源：

JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM | 2013年 / 26卷 / 1-2期

关键词：

DEND; K CNJ11; monogenic diabetes; sulfony lureas; V59A; NEONATAL DIABETES-MELLITUS; ACTIVATING MUTATIONS; KIR6.2; THERAPY;

D O I：

10.1515/jpem-2012-0236

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Heterozygous activating mutations of KCNJ11 (Kir6.2) are the most common cause of permanent neonatal diabetes mellitus (NDM), and successful glycemic control has been obtained in several cases with oral sulfonylureas (SU). We have verified a lack of clinical response for both glycemic control and neurological features in an infant with permanent neonatal diabetes mellitus and DEND syndrome due to a V59A mutation in the KCNJ11 gene. Thus, our case reinforces that most cases with DEND syndrome are insensitive to SU.

引用

页码：143 / 146

页数：4

共 50 条

[1] A V59M KCNJ11 gene mutation leading to intermediate DEND syndrome in a Chinese child
Sang, Yanmei
Ni, Guichen
Gu, Yi
Liu, Min
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2011, 24 (9-10): : 763 - 766
[2] DEND Syndrome with Heterozygous KCNJ11 Mutation Successfully Treated with Sulfonylurea
Cho, Ja Hyang
Kang, Eungu
Lee, Beom Hee
Kim, Gu-Hwan
Choi, Jin-Ho
Yoo, Han-Wook
JOURNAL OF KOREAN MEDICAL SCIENCE, 2017, 32 (06) : 1042 - 1045
[3] Monogenic diabetes due to mutation in the KCNJ11 gene
Frapolli, Victor Jose Simon
Montalban, Angel Lopez
Cesar, Maria Jose Picon
MEDICINA CLINICA, 2024, 163 (03): : 154 - 155
[4] Sulfonylurea treatment was ineffective in a patient with permanent diabetes mellitus and neurological symptoms caused by a KCNJ11 V59G mutation (DEND syndrome)
Sumnik, Zdenek
Kolouskova, Stanislava
Cinek, Ondrej
Vavrinec, Jan
HORMONE RESEARCH, 2006, 65 : 67 - 67
[5] Permanent neonatal diabetes due to KCNJ11 gene mutation
S. Letha
Darly Mammen
Joseph J. Valamparampil
The Indian Journal of Pediatrics, 2007, 74 : 947 - 949
[6] Sulfonylurea improves CNS function in a case of intermediate DEND syndrome caused by a mutation in KCNJ11
Wojciech Mlynarski
Andrei I Tarasov
Agnieszka Gach
Christophe A Girard
Iwona Pietrzak
Lejla Zubcevic
Jacek Kusmierek
Tomasz Klupa
Maciej T Malecki
Frances M Ashcroft
Nature Clinical Practice Neurology, 2007, 3 : 640 - 645
[7] Sulfonylurea improves CNS function in a case of intermediate DEND syndrome caused by a mutation in KCNJ11
Mlynarski, Woj Ciech
Tarasov, Andrei I.
Gach, Agnieszka
Girard, Christophe A.
Pietrzak, Wona
Zubcevic, Lejla
Kusmierek, Jacek
Klupa, Tornasz
Malecki, Maciej T.
Ashcroft, Frances M.
NATURE CLINICAL PRACTICE NEUROLOGY, 2007, 3 (11): : 640 - 645
[8] Permanent neonatal diabetes due to KCNJ11 gene mutation
Letha, S.
Mammen, Darly
Valamparampil, Joseph J.
INDIAN JOURNAL OF PEDIATRICS, 2007, 74 (10): : 947 - 949
[9] Successful transition to sulfonylurea in neonatal diabetes, developmental delay, and seizures (DEND syndrome) due to R50P KCNJ11 mutation
Pena-Almazan, Susan
DIABETES RESEARCH AND CLINICAL PRACTICE, 2015, 108 (01) : E18 - E20
[10] Transient Neonatal Diabetes due to Kcnj11 Mutation
Kochar, I. P. S.
Kulkarni, K. P.
INDIAN PEDIATRICS, 2010, 47 (04) : 359 - 360

← 1 2 3 4 5 →